Arcadia Biosciences (FRA:17D) ROCE %: -74.32% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:17D Arcadia Biosciences Inc FRA:17D
43 GF Score
Price €3.72
GF Value €15.09
! 4 Warning Signs
View Full Analysis

What is Arcadia Biosciences ROCE %?

Arcadia Biosciences FRA:17D 43 ROCE % is -74.32% as of Mar. 2026. GuruFocus rates FRA:17D with a GF Score™ of 43/100 and a GF Value™ of €15.09. The stock has 4 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Arcadia Biosciences's annualized ROCE % for the quarter that ended in Mar. 2026 was -74.32%.

Arcadia Biosciences  (FRA:17D) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Arcadia Biosciences ROCE % Related Terms

Arcadia Biosciences ROCE % Historical Data

* Premium members only.

The historical data trend for Arcadia Biosciences's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Arcadia Biosciences ROCE % Chart

Arcadia Biosciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -74.70 -49.80 -28.97 -57.60 -119.44

Arcadia Biosciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -44.18 -274.69 -91.21 -102.10 -74.32
FRA:17D
43GF Score
Arcadia Biosciences Inc FRA:17D
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Arcadia Biosciences ROCE % Calculation

Arcadia Biosciences's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=-8.536/( ( (12.909 - 2.448) + (5.59 - 1.758) )/ 2 )
=-8.536/( (10.461+3.832)/ 2 )
=-8.536/7.1465
=-119.44 %

Arcadia Biosciences's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=-2.696/( ( (5.59 - 1.758) + (4.604 - 1.181) )/ 2 )
=-2.696/( ( 3.832 + 3.423 )/ 2 )
=-2.696/3.6275
=-74.32 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -74.32% mean?
Arcadia Biosciences (FRA:17D) has a ROCE % of -74.32% as of Mar. 2026.
Is Arcadia Biosciences' ROCE % too high?
Arcadia Biosciences' current ROCE % is -74.32%. Overall, Arcadia Biosciences has a GF Score™ of 43/100, reflecting its overall financial health beyond just this single metric.
How does Arcadia Biosciences' ROCE % compare to ORISF and ARRT?
Arcadia Biosciences' ROCE % of -74.32% can be compared against companies in the Consumer Packaged Goods industry. The industry median ROCE % is 8.93. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Consumer Packaged Goods company?
The median ROCE % among Consumer Packaged Goods companies is 8.93, based on 1,942 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Consumer Packaged Goods industry, the median ROCE % is 8.93 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Arcadia Biosciences's current ROCE % is -74.32%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arcadia Biosciences stock overvalued right now?
Arcadia Biosciences (FRA:17D) has a current ROCE % of -74.32%. The stock's GF Value™ is €15.09, compared to a current price of €3.72 — trading 75.3% below its estimated fair value. The current ROCE % is -74.32%. Arcadia Biosciences' overall GF Score™ is 43/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Arcadia Biosciences (FRA:17D), the current ROCE % is -74.32% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Arcadia Biosciences (FRA:17D) Overvalued in 2026?

Based on GuruFocus' analysis, Arcadia Biosciences stock appears to be undervalued. The current stock price of €3.72 is trading 75.3% below its estimated GF Value™ of €15.09.

Key valuation signals for FRA:17D:

  • ROCE %: -74.32%
  • GF Value™: €15.09 vs. price of €3.72 (75.3% below fair value)
  • GF Score™: 43/100 with 4 warning signs

No single metric tells the full story. See the FRA:17D stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Arcadia Biosciences Business Description

Other Exchanges RKDA:USA
Address 5950 Sherry Lane, Suite 2000, Dallas, TX, USA, 75225
Arcadia Biosciences Inc is a company with science-based approaches to develop high value products and drive innovation in the consumer goods industry. The company has one operating and reportable segment, which derives revenue from the sale of Zola coconut water. The company's consumer brands in the food, beverage, and body care categories, and others. Its products include: Zola Coconut Water, and Agronomic Wheat Traits. Geographically, the company operates in United States, Argentina, India, and Canada. It derives maximum revenue from United States.
43GF Score

Get the complete analysis for FRA:17D

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.72
Price
€15.09
GF Value